Skip to content
Delayed ~15 min

NUVB NUVATION BIO CLASS A

Health Care · Russell 2000

Next earnings: not announced yet

What 14 analyst firms say about NUVATION BIO CLASS A: their latest ratings, price targets and how far the stock is from them. How it works

4.16 USD−0.03 (−0.72%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+212.5%to the avg target 13.00 USD+8.84 USD
Buy 12 · Hold 2 · Sell 0

14 rated views · 15 analyst/firm records · 14 firms

Latest report30 Sep 2026avg report date 8 Aug
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MNot scored · Price below 5 USD
  • Russell 2000 · Safest consensus · 6MNot scored · Price below 5 USD

Recent analyst activity · last 90 days

Our tracked history has 8 reports on NUVB from 7 analyst firms in the last 90 days (14 firms in the past year).

Comparing each firm's latest target with its previous one: 1 lowered it, 2 left it unchanged and 2 have their first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: RBC Capital lowered its target from $20.00 (set 7 Aug 2026) to $17.00 on 5 Nov 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
B Riley SecuritiesMayank MamtaniBuy29 Jun 202614.00 USD
Cantor FitzgeraldLi WatsekBuy21 Aug 2026—
CitigroupGeoff MeachamBuy19 Oct 202612.00 USD · 30 Sep 2026
Citizens JMPSilvan C TuerkcanBuy16 Sep 202610.00 USD
Citizens JMPSilvan TurkcanBuy16 Sep 202610.00 USD
H.C. WainwrightRobert BurnsBuy27 Jul 202621.00 USD
JonestradingSoumit RoyBuy5 May 202612.00 USD
JPMorganPriyanka GroverBuy18 Aug 202613.00 USD
RBC Capital MarketsLeonid TimashevBuy7 Aug 202620.00 USD
TD CowenYaron WerberBuy15 Jun 2026—
TruistGregory RenzaBuy7 Jul 202613.00 USD
UBSMichael J YeeHold7 Aug 20267.00 USD
WedbushDavid NierengartenBuy16 Sep 202611.00 USD
Weiss RatingsUnnamed analyst—15 Oct 2026—
Data feed RESEARCHResearch TeamHold6 Jul 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 06:00 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.